Advertisements

Podcast | Pick of the day: What Scott Gottlieb#39;s exit from USFDA means for the Indian pharma sector

Podcast | Pick of the day: What Scott Gottlieb#39;s exit from USFDA means for the Indian pharma sector.....»»

Category: topSource: moneycontrolMar 14th, 2019

Sensex, Nifty end 1% weaker as PSU banks, pharma slump

Sensex, Nifty end 1% weaker as PSU banks, pharma slump.....»»

Category: global-financeSource: reutersMay 13th, 2019

USFDA recommends action against Strides Pharma Science Puducherry unit

USFDA recommends action against Strides Pharma Science Puducherry unit.....»»

Category: topSource: moneycontrolMay 6th, 2019

Podcast | Stock picks of the day: PVR, Aurobindo Pharma Indian Hotels expected to gain

Podcast | Stock picks of the day: PVR, Aurobindo Pharma Indian Hotels expected to gain.....»»

Category: topSource: moneycontrolMay 2nd, 2019

Pharma packaging firm Scott Kaisha rides on Indian drug companies#39; injectables push

Pharma packaging firm Scott Kaisha rides on Indian drug companies#39; injectables push.....»»

Category: topSource: moneycontrolMar 15th, 2019

Podcast | Pick of the day - Binny Bansal out as Flipkart Group CEO - Moneycontrol.com

Podcast | Pick of the day - Binny Bansal out as Flipkart Group CEO - Moneycontrol.com.....»»

Category: topSource: googlenewsNov 14th, 2018

Podcast | Editor#39;s pick of the day - Tensions high in Kerala as Sabarimala Temple opens gates for all believers

Podcast | Editor#39;s pick of the day - Tensions high in Kerala as Sabarimala Temple opens gates for all believers.....»»

Category: topSource: moneycontrolOct 17th, 2018

Podcast | Editor’s pick of the day — Hot oil: Crude could climb to $100 a barrel; India to cut imports

Podcast | Editor’s pick of the day — Hot oil: Crude could climb to $100 a barrel; India to cut imports.....»»

Category: topSource: moneycontrolSep 25th, 2018

Podcast | Editor#39;s Pick of the Day: PSU chief appointments at 3 units may be delayed

Podcast | Editor#39;s Pick of the Day: PSU chief appointments at 3 units may be delayed.....»»

Category: topSource: moneycontrolAug 25th, 2018

Podcast | Pick of the day - Indian government approves net neutrality - Moneycontrol.com

Podcast | Pick of the day - Indian government approves net neutrality - Moneycontrol.com.....»»

Category: topSource: googlenewsJul 12th, 2018

Market Live: Midcap outperforms Nifty; rupee breaches 68$; Pharma stocks shine - Moneycontrol.com

Market Live: Midcap outperforms Nifty; rupee breaches 68$; Pharma stocks shine - Moneycontrol.com.....»»

Category: topSource: googlenewsJun 15th, 2018

Indian manufacturing PMI growth slows in May, inflationary pressures pick up

Indian manufacturing PMI growth slows in May, inflationary pressures pick up.....»»

Category: global-financeSource: reutersJun 1st, 2018

Indian pharma tussle for value status

Indian pharma tussle for value status.....»»

Category: topSource: moneycontrolMay 4th, 2018

Podcast | Aditya Ghosh"s exit and what it means for IndiGo - Moneycontrol.com

Podcast | Aditya Ghosh"s exit and what it means for IndiGo - Moneycontrol.com.....»»

Category: topSource: googlenewsApr 30th, 2018

Axis Bank shares climb as CEO exit seen as chance for change

Axis Bank shares climb as CEO exit seen as chance for change.....»»

Category: global-financeSource: reutersApr 10th, 2018

Indian Pharmaceutical Forum 2018: Challenges for pharma sector

Indian Pharmaceutical Forum 2018: Challenges for pharma sector.....»»

Category: topSource: moneycontrolFeb 24th, 2018

McKinsey IPA study: Decline in USFDA action on Indian pharma

McKinsey IPA study: Decline in USFDA action on Indian pharma.....»»

Category: topSource: moneycontrolFeb 23rd, 2018

More USFDA approvals do not mean better margins for Indian "big pharma"

More USFDA approvals do not mean better margins for Indian "big pharma".....»»

Category: topSource: business-standardJan 10th, 2018

More USFDA approvals do not mean better margins for Indian "big pharma"

More USFDA approvals do not mean better margins for Indian "big pharma".....»»

Category: topSource: business-standardJan 10th, 2018

Healthy trend: Indian pharma firms see rise in USFDA drug approvals in FY18

Healthy trend: Indian pharma firms see rise in USFDA drug approvals in FY18.....»»

Category: topSource: business-standardJan 2nd, 2018

USFDA vigil on Indian pharma companies to become more stringent

USFDA vigil on Indian pharma companies to become more stringent.....»»

Category: topSource: moneycontrolDec 18th, 2017